LONG ANDREW G (Chief Financial Officer) received a stock award from INSYS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2019ACC: 0001209191-19-034849
Officer· Chief Financial Officer
Since Aug 2018
+85.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
85.15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.47K
Price / share
—
Trade value
—
% of position
25.2%
4/17/2019
49.60K→62.08K
Total
Net shares
+12.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2019 | A · Award | +12.47K | — | — | 25.2% | 49.60K | 62.08K |
| Total | +12.47K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
72.67K shares
Shares
+72.67K
Strike price
4.30
Held after
72.67K
Exercisable
—
4/17/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock72.67K shares | 4/17/2019 | A · Award | +72.67K | 4.30 | — | 72.67K |